Non-interventional study
Safety and effectiveness of LORLAtinib as a FIRST-line treatment in an ALK-positive Advanced Non-Small Cell Lung Cancer Spanish population. (LORLA-FIRST).
Spain
EU PAS number:
EUPAS1000000406
First published:
04/06/2025
StudyPlanned
Comparative Effectiveness of Sotorasib Versus Docetaxel Monotherapy in Second Line and Beyond (2L+) Among Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in the Cancer Analysis System Database in England (20240164)
United Kingdom
EU PAS number:
EUPAS1000000405
First published:
16/04/2025
StudyOngoing
Effectiveness of ABRYSVO® maternal respiratory syncytial virus (RSV) vaccine against RSV in infants in Western Pennsylvania (CASSATT)
United States
EU PAS number:
EUPAS1000000389
First published:
17/02/2025
StudyPlanned
ConTTRibute: A Global Observational Multicenter Long-Term Study of Patients with Transthyretin (TTR)-Mediated Amyloidosis (ATTR amyloidosis)
Brazil
Bulgaria
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Taiwan
United States
EU PAS number:
EUPAS1000000381
First published:
07/05/2025
StudyOngoing
Effectiveness of Pfizer-BioNTech COVID-19 mRNA vaccine against severe illness in the elderly in Finland (RWE_COVID19_2023)
Finland
EU PAS number:
EUPAS1000000376
First published:
29/04/2025
StudyOngoing
Observational Cohort Study of Lasmiditan Exposure and Motor Vehicle Accidents in the United States (MI DRIVE) H8H-MC-B006
United States
EU PAS number:
EUPAS1000000347
First published:
20/11/2024
StudyPlanned
A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data (B7451085)
Denmark
France
Hungary
Spain
Sweden
EU PAS number:
EUPAS1000000345
First published:
07/01/2025
StudyOngoing
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
United States
EU PAS number:
EUPAS1000000334
First published:
14/10/2024
StudyOngoing
Etoricoxib in real-world clinical setting: it’s treatment outcome in patients with rheumatic diseases (RED)
Hungary
Latvia
EU PAS number:
EUPAS1000000317
First published:
23/09/2024
StudyFinalised
Postauthorisation Safety Study (PASS) of Avatrombopag in Patients With Severe Chronic Liver Disease (CLD)
Austria
Denmark
Netherlands
Spain
EU PAS number:
EUPAS1000000310
First published:
14/04/2025
StudyPlanned